Will emerging pharmacotherapies improve the management of polycystic ovarian syndrome?
Expert Opin Emerg Drugs
.
2016;21(1):1-4.
doi: 10.1517/14728214.2016.1132701.
Epub 2016 Jan 11.
Authors
Morena Luigia Rocca
1
,
Roberta Venturella
1
,
Rita Mocciaro
1
,
Fulvio Zullo
1
,
Michele Morelli
1
Affiliation
1
a Unit of Obstetrics and Gynaecology, Department of Experimental and Clinical Medicine , 'Magna Graecia' University , Catanzaro , Italy.
PMID:
26667609
DOI:
10.1517/14728214.2016.1132701
No abstract available
Publication types
Editorial
MeSH terms
Adolescent
Adult
Drug Design*
Female
Humans
Polycystic Ovary Syndrome / drug therapy*
Polycystic Ovary Syndrome / epidemiology
Polycystic Ovary Syndrome / physiopathology
Young Adult